NVDA Heads Into November Earnings With Institutional Flows Quietly Building

The Street's bull case remains intact but the valuation argument has not simplified. As noted in the September 30 note, targets from Bernstein ($400), Rosenblatt ($390) and JP Morgan ($320) all sit well above the current price level, implying upside of 40% or more. That gap has not closed meaningfully over the week. The ORTEX factor scores back the quality case: an EPS momentum rank in the 79th percentile over 30 days and 76th over 90 days, a return-on-assets reading cited at 58% in the recent stock-score note, and an EV/EBIT rank at the 71st percentile. The one persistent drag is valuation itself, with the value score anchored low by an elevated price-to-book. The short score rank at the 83rd percentile is worth noting: it reflects how the lending and positioning data score relative to the broader universe, not an alarm, but a reminder that NVDA is not a name where shorts are fleeing.

The price data in this snapshot reflects the Argentine peso-denominated listing on BASE, where the stock closed at ARS 15,850, up 10.1% over the past month. The underlying US-listed price of $227.21 (from the September 30 note) remains the relevant reference for the targets and multiples discussed here. The two series move together but the ARS figures should not be read against dollar-denominated analyst targets.

Looking ahead, the November 25 earnings date is the obvious focal point. The most recent comparable print, in August, produced a one-day move of 7.2% and a five-day follow-through of 4.8%. The prior quarter saw a one-day decline of 0.6% and a five-day drift of negative 2.4%, a reminder that even strong prints can produce muted or negative near-term reactions when expectations are already elevated. Whether the current institutional accumulation translates into a compressed reaction or amplifies the move is the question the next few weeks of positioning data will begin to answer.